Experimental drug targets currently untreatable type of lung cancer

[News]

Scientists at Stanford and UC-San Francisco have developed an experimental drug that targets a currently untreatable type of lung cancer responsible for generating roughly 500,000 newly diagnosed cases worldwide each year.

More... (https://www.news-medical.net/news/20191107/Experimental-drug-targets-currently-untreatable-type-of-lung-cancer.aspx)